Dafna Capital Management LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $162,091 - $1.01 Million	-108,061 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.79 - $8.39 $3.06 Million - $5.36 Million	-639,239 Reduced 85.54%	108,061 $907,000
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $1.55 Million - $3.24 Million	450,000 Added 151.36%	747,300 $3.92 Million
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $50,820 - $60,060	-7,700 Reduced 2.52%	297,300 $2.06 Million
Q1 2019 May 15, 2019	BUY	$5.76 - $8.95 $864,000 - $1.34 Million	150,000 Added 96.77%	305,000 $2.12 Million
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $815,300 - $1.24 Million	155,000 New	155,000 $905,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.12B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.